# Febuxostat

## Feburic 80mg

| TAH Drug Code      | [OFEB](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OFEB)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Chronic hyperuricaemia where urate deposition had occurred including history or presence of tophus &/or gouty arthritis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | Gout: Initial dose: 40mg QD. If the serum uric acid concentration is not lower than 6mg/dL after taking the medicine for 2 weeks, change to 80mg QD. Tumor lysis syndrome: Two days before the start of cytotoxic drug treatment, 80 mg QD for 7 days. According to the clinical response during chemotherapy, it can be extended to 9 days.                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Contraindications  | Hypersensitivity. Concomitant use of azathioprine or mercaptopurine.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | (common): ■Dermatologic: Rash (0.5% to 1.6% ) ■Gastrointestinal: Nausea (1.1% to 1.3% ) ■Hepatic: Liver enzymes abnormal (4.6% to 6.6% ) ■Musculoskeletal: Arthralgia (0.7% to 1.1% ), Gout, acute 副作用 (serious) ■Cardiovascular: Death, Cardiovascular, Myocardial infarction ■Dermatologic: Stevens-Johnson syndrome ■Hematologic: Idiopathic thrombocytopenic purpura (less than 1% ) ■Hepatic: Hepatitis (less than 1% ), Liver failure ■Immunologic: Anaphylaxis, Immune hypersensitivity reaction (less than 1% ) ■Musculoskeletal: Rhabdomyolysis ■Neurologic: Cerebrovascular accident (less than 1% ), Transient ischemic attack (less than 1% ) ■Renal: Renal failure (less than 1% ), Tubulointerstitial nephritis ■Other: Angioedema (less than 1% ) |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

